Sfoglia per AUTORE
GARCíA-CADENAS I
Collezione AOU Città della Salute di Torino
Items : 2
Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy. in Bone marrow transplantation / Bone Marrow Transplant. 2024 Jan;59(1):52-58. doi: 10.1038/s41409-023-02127-9. Epub 2023 Oct 21.
2024
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Shadman M; Yáñez San Segundo L; Sadetsky N; Pigneux A; Ljungman P; Kumar D; Guzman-Becerra N; Fagioli F; Chevallier P; García-Cadenas I; Sanz J; Barlev A; Barba P; Socié G; Storek J; Thirumalai D; Xing B; Mohty M;
Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment. in Transplantation and cellular therapy / Transplant Cell Ther. 2022 May;28(5):258.e1-258.e8. doi: 10.1016/j.jtct.2022.01.026. Epub 2022 Feb 4
2022
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Gahrton G; García-Cadenas I; Reguera JL; López-Corral L; Nahi H; Granell M; Einsele H; Bruno B; Fanin R; Herrera P; Patriarca F; Reinoso-Segura M; Caballero-Velázquez T; Pérez-Simón JA;